The proposed starting up doses for retatrutide range across medical trials and health care resources as researchers get the job done to search out best protocols. Frequent starting doses involve: Retatrutide is the newest fat reduction medication that acts to be a triple agonist at GLP-1, GIP, and glucagon receptors. https://corepepptides.com/product/retatrutide-injection-pen/